Figure 3.
Correlation between anti-FIIa bioassays and the LC-MS/MS method on 100 dabigatran plasma samples from the RELY or phase 1 studies. (A) HEMOCLOT™ TI and (B) BIOPHEN™ direct thrombin inhibitor (DTI).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.